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Over the last 15 years, the systematic implementation of an 
evidence-based perioperative care protocol (“fast-track” or 
“enhanced recovery pathway”), such as that developed by 
the Enhanced Recovery After Surgery (ERAS) Society, has 
shown that hospital length of stay and complications can be 
reduced for a number of surgical procedures (Ljungqvist et 
al. 2017). For total hip (THR) and total knee replacement sur-
gery (TKR), high-volume models have reduced length of stay 
from 4–10 days to 1–3 days, and outpatient surgery is pos-
sible for around 15% of patients in unselected cohorts within 
a socialized health systems (den Hartog et al. 2013, Kehlet 
2013, Khan et al. 2014, Aasvang et al. 2015, Gromov et al. 
2017). Given the proven benefit to both the patient and the 
healthcare system, ERAS protocols have been published for 
rectal, urological, pancreatic, gastric, breast, and reconstruc-
tive surgery, head and neck cancer surgery, bariatric, and liver 
surgery (Cerantola et al. 2013, Nygren et al. 2012, Lassen et 
al. 2012, Melloul et al. 2016, Mortensen et al. 2014, Thorell et 
al. 2016, Dort et al. 2017, Temple-Oberle et al. 2017). 
In Denmark, hip and knee replacement surgery has since 
year 2009 been coordinated nationally across select high-
volume centers, adopting and developing a unified periopera-
tive protocol, and a basis for research that has advanced the 
knowledge base for elective hip and knee replacement (Kehlet 
2013). In the United Kingdom (UK), a national enhanced 
recovery partnership program ran between 2009 and 2011 
with the aim to spread the best practice developed for hip and 
knee replacement based on work from UK high-volume cen-
ters (Wainwright and Middleton 2010, Malviya et al. 2011, 
McDonald et al. 2012). However, despite these efforts and 
previous narrative reviews on fast-track/enhanced recovery 
protocols for THR and TKR (Ibrahim et al. 2013a, 2013b; 
Background and purpose — There is a large volume of 
heterogeneous studies across all Enhanced Recovery After 
Surgery (ERAS®) components within total hip and total 
knee replacement surgery. This multidisciplinary consensus 
review summarizes the literature, and proposes recommen-
dations for the perioperative care of patients undergoing total 
hip replacement and total knee replacement with an ERAS 
program.
Methods — Studies were selected with particular atten-
tion being paid to meta-analyses, randomized controlled 
trials, and large prospective cohort studies that evaluated the 
efficacy of individual items of the perioperative treatment 
pathway to expedite the achievement of discharge criteria. A 
consensus recommendation was reached by the group after 
critical appraisal of the literature.
Results — This consensus statement includes 17 topic 
areas. Best practice includes optimizing preoperative patient 
education, anesthetic technique, and transfusion strategy, in 
combination with an opioid-sparing multimodal analgesic 
approach and early mobilization. There is insufficient evi-
dence to recommend that one surgical technique (type of 
approach, use of a minimally invasive technique, prosthesis 
choice, or use of computer-assisted surgery) over another 
will independently effect achievement of discharge criteria.
Interpretation — Based on the evidence available for 
each element of perioperative care pathways, the ERAS® 
Society presents a comprehensive consensus review, for the 
perioperative care of patients undergoing total hip replace-
ment and total knee replacement surgery within an ERAS® 
program. This unified protocol should now be further evalu-
ated in order to refine the protocol and verify the strength of 
these recommendations.
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Sprowson et al. 2013), a systematic and evidence-based guide-
line has not been produced. The present work brought together 
a group of ERAS experts to interpret the evidence using the 
GRADE system for rating quality of evidence and strength of 
recommendations (Guyatt et al. 2008).
The scope of these guidelines includes only the periopera-
tive period, with evidence examined on the ability of different 
interventions to reduce perioperative stress, maintain and sup-
port homeostasis and physiological function, and importantly 
accelerate the achievement of discharge criteria, including 
minimizing complications. Whilst the site of replacement is 
an independent factor for recovery, wherever possible we have 
prioritized procedure level evidence and applied critical analy-
sis to studies that have included both THR and TKR. 
This article represents the efforts of the ERAS Soci-
ety (http://www.erassociety.org) to present an updated and 
expanded consensus review of perioperative care for hip and 
knee replacement based on current evidence.
Methods
Development of consensus recommendations 
A panel of experts in total hip replacement and total knee 
replacement was convened. This working group comprised 
surgeons, a physician, an anesthetist, and physiotherapists. A 
nursing perspective was also incorporated through the consid-
eration and inclusion of qualitative nursing-specific literature 
(Specht et al. 2015, 2016). Previous ERAS Society guidelines 
were reviewed and used as a methodological template (Gus-
tafsson et al. 2013). The panel was asked to advise on appro-
priate topics to be included in the guidelines, with final deci-
sions being made by the lead authors (TW, OL). Once agreed, 
topics were allocated to authors, depending on each individu-
al’s expertise. The final paper was agreed upon by all authors. 
Literature search and study selection 
Search terms were created using MESH terms and key words, 
and searches were carried out using the Bournemouth Uni-
versity MySearch interface (Bournemouth University), which 
includes Medline, CINAHL, Science Direct, PsycINFO, and 
Cochrane Database of Systematic Reviews databases. Whilst 
ERAS has evolved over the last 10–15 years, for complete-
ness the peer-reviewed and English-language literature was 
systematically reviewed from January 1966 to October 2018. 
We appreciate that evidence from ERAS studies is evolving 
at a fast rate and so future studies may impact on findings; 
however, the recommendations presented are considered to 
reflect evidence at the time of writing (January 2019). Preop-
erative, surgical, anesthetic and analgesia, postoperative, and 
rehabilitation topics were searched. Reference lists of eligible 
articles were also reviewed for other relevant studies. Key 
words included “hip replacement,” “hip arthroplasty,” “knee 
replacement,” “knee arthroplasty,” “hip prosthesis,” “knee 
prosthesis,” and additional keywords were added depending 
on the topic. 
The authors screened titles and abstracts to identify poten-
tially relevant articles, and reference lists of eligible articles 
were hand-searched for relevant studies. Systematic reviews, 
meta-analyses, randomized controlled trials, and non-ran-
domized trials were considered for each topic, unless there 
were few papers identified, in which case all papers were 
screened. Qualitative studies were also considered in specific 
areas, where “hands on” experience of ERAS was described. 
We consider that although these do not qualify as high-level 
evidence, they provide valuable evidence on issues such 
as how patients perceive the ERAS pathway, and the role 
that nurses play. We carefully reviewed the final literature 
selected, and any discrepancies were resolved through group 
consensus. Studies in ERAS or fast-track set-ups showing 
improvements in the achievement of discharge criteria, or 
reducing length of stay, or having a positive effect on compli-
cations were targeted. 
Quality assessment and data analyses 
The overall quality of evidence was assessed using criteria 
developed by the Centre for Evidence Based Medicine at 
Oxford, England. Possible levels of evidence included “high” 
(i.e., systematic reviews, meta-analyses, or robust random-
ized controlled trials), “moderate” (i.e., smaller randomized 
controlled trials or prospective cohort data), or “low” (i.e., 
retrospective data). In line with ERAS guidelines for other 
surgical procedures (Gustafsson et al. 2013) the Grading of 
Recommendations, Assessment, Development and Evalu-
ation (GRADE) system was used to evaluate the quality 
of evidence and recommendations (Tables 1 and 2, Guyatt 
et al. 2008). Recommendations are made based on whether 
the evidence level is high, medium, low, or very low qual-
ity, and the strength of the recommendation is based on the 
balance between desirable and undesirable effects. As with 
other ERAS working groups (Cerantola et al. 2013, Gustafs-
son et al. 2013), a GRADE evaluation may result in a strong 
recommendation even when based on low-quality data, if the 
risk of harm is negligible. Conversely, a weak recommenda-
Table 1. GRADE system for rating quality of evidence (Guyatt et al. 
2008)
Evidence level Definition
High quality Further research unlikely to change confidence in 
  estimate of effect
Moderate quality Further research likely to have important impact 
  on confidence in estimate of effect and may 
  change the estimate
Low quality Further research very likely to have important 
  impact on confidence in estimate of effect and  
  likely to change the estimate
Very low quality Any estimate of effect is very uncertain
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tion may result from high-quality data. Any disagreements in 
the assessment of quality of evidence and grading of recom-
mendation statements were resolved through consensus dis-
cussions. We were judicious when providing strong recom-
mendations in areas where there was weak procedure-specific 
evidence. This was to ensure that new non-evidenced based 
traditions within ERAS were not created, when previous 
work in ERAS for THA and TKA has cautioned against this 
(Husted et al. 2014). 
Evidence base and recommendations—ERAS items
Preoperative information education and counselling
Preoperative patient education has not been shown to inde-
pendently affect postoperative outcomes, such as accelerating 
the achievement of discharge criteria, but it has been found 
to reduce preoperative anxiety across a number of systematic 
reviews (Bergin et al. 2014, Jordan et al. 2014, Louw et al. 
2013), including a Cochrane review (McDonald et al. 2014). 
However, the conclusions of these reviews may be flawed due 
to the heterogeneity of the pooled studies. There is a strong 
need for properly designed randomized and controlled stud-
ies that are sufficiently powered, performed in ERAS settings, 
and allow for discrimination between outcome parameters. 
Further information on what type of information should be 
given, at what point, by whom, and, for example, whether it 
should it be graded between younger active, older active, and 
older sedentary patients is required. Whilst strong specific 
evidence may be lacking to recommend preoperative educa-
tion and counselling, qualitative studies detailing the patient 
perspective highlight the importance of patients getting the 
right information and support (Specht et al. 2016). Preopera-
tive education is also unlikely to cause harm and is delivered 
in differing forms within all established hip and knee replace-
ment ERAS centers. This means that it is a strongly recom-
mended component. 
Summary/recommendation—Preoperative patient education 
is recommended 
Evidence level—Low
Recommendation grade—Strong
Preadmission patient optimization
Optimizing preoperative risk factors, such as smoking, alco-
hol consumption, anemia, nutritional and metabolic status, 
and low physical activity, that may lead to complications or 
a prolonged length of stay, could potentially benefit a large 
proportion of hip and knee replacement patients (Hansen et al. 
2012). In the ERAS specific literature, preoperative screening 
and intervention has helped reduce the number of patients with 
delayed recovery (Hansen et al. 2012). The effect of specific 
individual factors on ERAS outcomes is considered below.
Smoking cessation
The risk of an increased length of stay and other early postop-
erative complications for patients who smoke has been found 
to be reduced within established ERAS pathways (Jorgensen 
and Kehlet 2013). However, the association between current 
and former smoking and a substantially higher risk of post-
operative complications and mortality post-surgery has level 
1 evidence (Singh 2011). There is level 2 evidence across 
surgical studies to show that referral to a smoking cessation 
program 4 weeks preoperatively is associated with fewer 
complications, especially wound-related problems (Moller et 
al. 2002, Mills et al. 2011, Mak et al. 2014, Thomsen et al. 
2014). 
Summary/recommendation—4 weeks or more smoking ces-
sation is recommended before hip and knee replacement
Evidence level—High
Recommendation grade—Strong
Alcohol
A large retrospective study found that hip and knee replace-
ment patients who misused alcohol had a longer length of 
stay and were more likely to have medical and surgery related 
complications (Best et al. 2015). However, whilst this risk 
of a longer length of stay and other early postoperative com-
plications may be less for patients on exemplar hip and knee 
replacement ERAS pathways (Jorgensen and Kehlet 2013), in 
line with evidence from other surgical procedures and public 
health recommendations, alcohol cessation interventions 
before surgery should be utilized to reduce complications in 
patients with high alcohol intake (Oppedal et al. 2012). 
Summary/recommendation—Alcohol cessation programs are 
recommended before hip and knee replacement
Evidence level—Low
Recommendation grade—Strong
Anemia
Preoperative anemia is associated with an increased risk of 
transfusion, length of stay, infection, morbidity, and readmis-
sion rates (Kehlet 2013, Munoz et al. 2014), with the prev-
alence in elective hip and knee surgery reported as ranging 
from 15–39% (Spahn 2010). 
Table 2. GRADE system for rating strength of recommendations 
(Guyatt et al. 2008)
Recommendation
strength Definition
Strong When desirable effects of intervention clearly outweigh the 
 undesirable effects, or clearly do not
Weak When trade-offs are less certain—either because of 
 low-quality evidence or because evidence suggests desir
 able and undesirable effects are closely balanced
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RCTs and cohort studies of interventions such as preop-
erative iron or erythropoietin therapy and postoperative re-
transfusion of salvaged cells in general report a statistically 
significant and clinically relevant reduction in allogeneic 
blood transfusion (Munoz et al. 2014, Theusinger el al. 2014). 
Algorithm-led preoperative anemia screening in established 
ERAS centers has also been associated with reduced RBC 
transfusion, readmission, critical care admission, length of 
stay, and costs (Pujol-Nicolas et al. 2017). The cause of the 
anemia must also be investigated and managed.
Summary/recommendations—Preoperative anemia should 
be identified, investigated, and corrected prior to hip and 
knee replacement.
Evidence level—High
Recommendation grade—Strong
Preoperative physiotherapy
Preoperative physiotherapy (including exercise programs) has 
been proposed as an intervention to expedite discharge (Carli 
and Zavorsky 2005). However, whilst preoperative physio-
therapy may slightly improve early postoperative pain and 
function, the effects of the intervention in isolation remain too 
small to be considered clinically important and do not acceler-
ate achievement of discharge criteria or shorten length of hospi-
tal stay (Wang et al. 2016). In addition, 1–2 day length of stay 
for unselected patients and outpatient surgery for hip and knee 
replacement has been achieved without preoperative physiother-
apy (Gromov et al. 2017). Several reviews of RCTs of variable 
quality indicate little clinical benefit from preoperative physio-
therapy (Wang et al. 2016, Moyer et al. 2017, Chen et al. 2018). 
There is emerging work examining the addition of nutrition 
therapy and psychological preparation to exercise regimes, in 
a concept called prehabilitation. These programs have shown 
improvements to recovery in general surgical procedures 
(Carli and Scheede-Bergdahl 2015). However, procedure spe-
cific studies in hip and knee replacement are needed before 
recommendation, and the effect may only be seen in specific 
patient groups, such as elderly and frail patients, patients with 
special needs or multiple comorbidities, patients with psychi-
atric diseases, and patients not currently able to achieve dis-
charge on the day of surgery (Bandholm et al. 2018).
Summary/recommendation—Current evidence does not sup-
port preoperative physiotherapy as an essential intervention 
Evidence level—Moderate (for not recommending)
Recommendation grade—Strong 
Preoperative fasting
Recent anesthetic guidelines indicate that the intake of clear 
fluids until 2 hours before surgery does not increase gastric 
content, reduce gastric fluid pH, or increase complication rates. 
Therefore, the intake of clear fluids until 2 hours before the 
induction of anesthesia as well as a 6-hour fast for solid food 
is recommended (Smith et al. 2011). To facilitate this, specific 
guidelines should be provided to each individual patient depend-
ing on their time of surgery and place on the operating list. 
Summary and recommendation—Intake of clear fluids until 2 
hours before the induction of anesthesia, and a 6-hour fast 
for solid food is recommended
Evidence level—Moderate
Recommendation grade—Strong
Preoperative carbohydrate treatment
Carbohydrate loading has been shown to reduce insulin resis-
tance in various surgical procedures including orthopedic 
surgery (Nygren 2006, Awad et al. 2013). Meta-analysis data 
suggest shorter length of stay after major abdominal surgery 
but not in hip and knee replacement (Smith et al. 2014). In 
hip replacement, some small RCTs show positive effects 
on preoperative hunger and nausea, and postoperative pain 
(Harsten et al. 2012) as well as on glucose metabolism (Soop 
et al. 2004) and insulin resistance (Nygren et al. 1999), while 
others show no effect (Ljunggren and Hahn 2012). Whilst 
carbohydrate loading may improve patient well-being peri-
operatively (Harsten et al. 2012), outpatient surgery (Gromov 
et al. 2017) and routine 1–2-day length of stay on unselected 
patients (Aasvang et al. 2015) is achievable without carbohy-
drate loading. Therefore, the current evidence does not sup-
port the routine use of carbohydrate loading; however, future 
research may elicit benefits for more elderly and frail patients, 
and patients with multiple comorbidities.
Summary/recommendation—In hip and knee replacement 
carbohydrate loading may improve patient well-being and 
metabolism, but it has not been shown to accelerate the 
achievement of discharge criteria or reduce complications, 
and so it is not currently recommended as an essential rou-
tine intervention 
Evidence level—Moderate (for not recommending)
Recommendation grade—Strong
Pre-anesthetic medication
Sedative or anxiolytic drugs may be used to promote patient 
comfort and/or facilitate the successful completion of technical 
procedures such as spinal anesthesia. However, their use is not 
universal and side effects may include postoperative sedation. 
There are minimal data available (for or against) to support the 
preoperative use of sedative or anxiolytic medication to reduce 
anxiety and accelerate the achievement of discharge criteria 
(Moiniche et al. 2002). If indicated, short-acting sedative drugs 
may be used by the clinician to facilitate successful completion 
of technical procedures, but routine administration of sedatives 
to reduce anxiety preoperatively should be avoided.
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Summary and recommendation—The routine administration 
of sedatives to reduce anxiety preoperatively is not recom-
mended
Evidence level—Low 
Recommendation grade—Strong
Standardized anesthetic protocol
A core component of hip and knee replacement ERAS path-
ways is a standardized anesthetic protocol. However, the com-
ponents of these protocols differ, and a lack of methodological 
quality, reporting detail, and homogeneity of outcome mea-
sures makes direct comparison of techniques in ERAS settings 
difficult (Kehlet and Aasvang 2015). 
The use of general versus central neuraxial anesthesia
In general, large multi-center cohorts of exemplar ERAS hip 
and knee replacement pathways favor neuraxial techniques 
over general anesthesia, and this change in practice has been 
at the core of established ERAS pathways (McDonald et al. 
2012, Khan et al. 2014). Large epidemiological studies (albeit 
in non-ERAS set ups) show that central neuraxial anesthesia 
is independently associated with better outcomes compared 
with general anesthesia (Memtsoudis et al. 2013). Conversely, 
emerging research from 2 single-center RCTs in established 
ERAS centers has questioned whether the reduced cardiopul-
monary and thromboembolic complications associated with 
neuraxial techniques (Harsten et al. 2013, 2015b are as rel-
evant in an ERAS set up. A modern general anesthetic was 
compared with a traditional high dose of neuraxial anesthesia 
(bupivacaine 0.5% 3 mL), and no clinically relevant differ-
ences in functional recovery, length of stay, urinary complica-
tions, and mobilization were found. However, further studies 
are needed to compare modern general anesthetic and neur-
axial anesthesia practices. General anesthesia may also reduce 
urinary bladder dysfunction, and rare but potentially severe 
neurological complications (Kehlet and Aasvang 2015). 
Future multi-center RCTs are required to further compare 
the safety issues and potential differences in postoperative 
morbidity between the 2 anesthetic techniques with specific 
emphasis on detailing the components of each technique, e.g., 
type of spinal.
Summary and recommendations—Modern general anesthe-
sia and neuraxial techniques may both be used as part of 
multimodal anesthetic regimes
Evidence level—Moderate (modern general anesthesia), 
moderate (neuraxial techniques)
Recommendation grade—Strong
Spinal (intrathecal) opioids
There has been considerable interest in the use of opioids as 
an addition to local anesthetic in spinal anesthesia for hip and 
knee replacement. Whilst spinal opioids have been shown to 
lower pain scores and analgesic use (Cole et al. 2000), they 
increase the risk of urinary retention, pruritus, and respiratory 
depression (Gehling and Tryba 2009, Fernandez et al. 2014). 
Side effects may be avoided when lower doses are used, how-
ever, any superior effect on pain is then lost compared to alter-
native techniques such as local infiltrative analgesia (LIA) in 
knee replacement (Andersen and Kehlet 2014). Therefore, 
despite the analgesic benefits, the potential for unwanted side 
effects such as respiratory depression, postoperative nausea 
and vomiting, and pruritus does not support the routine use of 
spinal opioids.
Summary and recommendations—Spinal opioids are not rec-
ommended for routine use
Evidence level—Moderate
Recommendation grade—Strong
Epidurals
Lumbar epidurals have been accepted as providing favorable 
analgesia postoperatively for lower limb surgery. However, 
there are potential side effects that delay recovery and these 
include hypotension, urinary retention, pruritus, and motor 
blockade. Also, serious complications such as permanent 
nerve damage are rare, but remain a concern (Choi et al. 2003, 
Rawal 2012). Alternative means of postoperative analgesia are 
now more effective and commonly used after uncomplicated 
knee or hip replacement.
Summary and recommendations—Epidural analgesia is not 
recommended for routine use in hip and knee replacement 
because of the potential for adverse effects which delay 
recovery
Evidence level—High (analgesic efficacy), moderate (nega-
tive safety and side-effect profile)
Recommendation grade—Strong
Use of local anesthetics for nerve blocks and infiltra-
tion analgesia
Local infiltration analgesia (LIA) has an advantage over nerve 
blocks, because it produces no motor blockade. This can allow 
for earlier safe ambulation with a reduction in the side effects 
associated with both nerve blocks and epidural analgesia, 
where hypotension and urinary retention can cause additional 
problems.
Concerns with LIA have been raised regarding potential 
risks of local anesthetic toxicity, wound healing, and infec-
tion (McCartney and McLeod 2011). However, several reports 
have demonstrated that toxic levels do not appear to be reached 
using techniques described (Affas et al. 2011, Brydone et al. 
2015). Several case series with long-term follow-up also dem-
onstrate no increased risk of joint infection when using LIA 
compared with previous published data (Malviya et al. 2011, 
McDonald et al. 2012, 2016).
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A review of the literature on LIA in total hip and knee 
replacement concludes that there is little evidence to support 
using this technique in hip replacement either intraoperatively 
or with a postoperative wound infusion catheter technique, 
as long as multimodal, oral non-opioid analgesia is given 
(Andersen and Kehlet 2014). For knee replacement, meta-
analysis data support the intraoperative use of LIA (Yun et al. 
2015), but not wound catheter administration postoperatively 
(Andersen and Kehlet 2014). There are no firm data suggest-
ing one method of infiltration or a specific combination of 
drugs and dosage over another in LIA.
There are several nerve block techniques that may be used. 
Femoral nerve blockade has been compared and reviewed 
against epidurals and PCAs with advantages such as reducing 
the risk of hypotension and the use of opioids (Fowler et al. 
2008, Paul et al. 2010, Chan et al. 2014). However, the main 
problem is its negative effect on mobilization (Kandasami et 
al. 2009, Ilfeld et al. 2010, Sharma et al. 2010). Whilst femoral 
nerve block is an effective analgesic technique following knee 
replacement, concerns remain regarding the impact on muscle 
function and early mobilization, with an increased risk of falls 
(Sharma et al. 2010).
The Hunter Canal block is an alternative to the femoral 
nerve block and is proposed to offer better preserved quadri-
ceps muscle strength and mobilization ability in the 48 hours 
post-surgery (Jaeger et al. 2013, Perlas et al. 2013). However, 
conclusive data showing superiority has not been proven in 
established ERAS pathways. 
The addition of a sciatic nerve block to the postoperative 
analgesic regimen following hip and knee replacement has not 
been found to provide substantial benefit (Paul et al. 2010) 
over any of the other alternative local techniques or the use 
of no local technique when assessed as part of a multimodal 
opioid-sparing analgesic regime.
Summary and recommendations—LIA is recommended 
for knee replacement but not for hip replacement within a 
multi-modal opioid sparing regime. Nerve block techniques 
provide equal analgesia; however, when compared with LIA 
prolonged motor blockade may limit early and safe mobili-
zation. Nerve blocks are therefore not recommended as an 
essential ERAS component
Evidence level for LIA in knee replacement—High
Recommendation grade—Strong
Postoperative nausea and vomiting
Postoperative nausea and vomiting (PONV) is distressing for 
patients and can lead to notable patient morbidity and an asso-
ciated prolonged length of hospital stay. In general, female 
gender, a past history of motion sickness or PONV, and being 
a non-smoker are all risk factors for PONV (Apfel et al. 1999). 
Several classes of first-line medications are available: dopa-
mine (D2) antagonists (e.g., droperidol), serotonin (5HT3) 
antagonists (e.g., ondansetron), and corticosteroids (e.g., 
dexamethasone). Studies have shown that combinations of the 
drugs enhance their efficacy (Eberhart et al. 2002, Apfel et al. 
2004). Therefore, in patients with 1 to 2 risk factors a combi-
nation of 2 drugs is often recommended, and, in patients with 
higher risk, three drugs in combination. If rescue treatment is 
required despite prophylaxis, drugs from classes not yet used 
should be employed (Gan et al. 2014).
Summary and recommendation—Evidence supports the use 
of screening for and multimodal PONV prophylaxis and 
treatment for patients undergoing hip and knee replacement
Evidence level—Moderate 
Recommendation grade—Strong 
Prevention of perioperative blood loss—tranexamic acid
Hip and knee replacement has been associated with pro-
nounced blood loss (Liu et al. 2011), which, traditionally, has 
been healed by blood transfusion. However, its use carries 
risks including transfusion reaction, disease transmission, 
coagulopathy, renal failure, deep infection, and death (Juels-
gaard et al. 2001). Studies are also required to evaluate the 
optimal transfusion triggers, especially in high-risk patients, 
where a lack of data has prevented inclusion in recent transfu-
sion guidelines (Munoz et al. 2017, 2018). Historically, it has 
been shown to add to the cost of an operation and increase 
hospital stay (Newman et al. 1997). Decreasing blood loss 
and thus need for transfusion at the intraoperative stage may 
be achieved using combined local and systemic tranexamic 
acid, as this stops the breakdown of fibrin clot by inhibiting 
activation of plasminogen, plasmin, and tissue plasminogen 
activator. Studies have found it to be both efficient and safe 
(Rajesparan et al. 2009, Husted et al. 2010, 2014, Henry et 
al. 2011) despite previous concerns of an increased risk of 
venous thromboembolic events; and recent RCTs and meta-
analyses support combined systemic and/or intra-articular 
administration (Nielsen et al. 2016, Shang et al. 2016, Zhang 
et al. 2017).
Summary and recommendation—Tranexamic acid is recom-
mended to reduce perioperative blood loss and the require-
ment for postoperative allogenic blood transfusion
Evidence level—High 
Recommendation grade—Strong 
Multimodal analgesia
Combining oral analgesics of different classes and with dif-
ferent modes of action has been shown to yield additive pain 
relief (Ong et al. 2010). This is an effective way of limiting the 
use of opioids perioperatively and thereby avoiding their well-
known side effects. In addition, prolonged opioid use in and 
after surgery is a leading risk factor for longer term addiction 
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and so should be avoided (Clarke et al. 2014). The use of mul-
timodal non-opioid oral analgesia is one of the cornerstones of 
exemplar ERAS hip and knee replacement pathways (McDon-
ald et al. 2012, Khan et al. 2014). Paracetamol and non-steroi-
dal anti-inflammatory drugs (NSAIDs) are the mainstay.
Optimal pain management is a prerequisite of ERAS and 
alternative analgesic drugs (such as glucocorticoids and ket-
amine) have been described for hip and knee replacement. 
Simple systemic techniques such as the addition of a high-
dose preoperative glucocorticoid to multimodal regimes have 
been shown to be safe and effective in knee and hip replace-
ment (Mathiesen et al. 2008, Lunn et al. 2011). However, there 
is a need for further data on dosage use in hip replacement 
patients and in at-risk groups such as high-pain responders. 
Paracetamol
Paracetamol is regularly prescribed perioperatively and within 
ERAS pathways. It reduces pain and morphine consumption 
over a 24-hour period in patients undergoing both hip and knee 
replacement (Sinatra et al. 2005). Although not specific to hip 
and knee replacement, paracetamol has been shown to reduce 
PONV if given prophylactically before surgery or arrival in 
the postoperative care unit and this correlated with a reduc-
tion in pain scores but not postoperative opioid use (Apfel et 
al. 2013). Paracetamol can reduce acute postoperative pain, 
has a favorable side-effect profile, and is a core component 
of multimodal analgesia in all exemplar hip and knee ERAS 
pathways. 
Summary and recommendations—The routine use of 
paracetamol is recommended 
Evidence level—Moderate
Recommendation grade—Strong
Non-steroidal anti-inflammatory drugs (NSAIDs)
Studies have shown that NSAIDs decrease pain and reduce 
supplemental analgesic (opioid) use following hip and knee 
replacement (Buvanendran et al. 2003, Huang et al. 2008). 
Level 1 evidence of postoperative analgesia following knee 
replacement determined that NSAIDs should be recom-
mended for their analgesic and opioid-sparing effects (Fischer 
et al. 2008). NSAIDs are a central tenant of multimodal anal-
gesia in exemplar hip and knee replacement ERAS pathways, 
and there is evidence from a randomized controlled trial that 
indicates no increase in perioperative blood loss, and accom-
panying reduction in pain (Meunier et al. 2007. However, indi-
vidual patient risk should be assessed including the potential 
for bleeding complications, gastroduodenal ulcer history, car-
diovascular morbidity, aspirin-sensitive asthma, and renal and 
hepatic function. Due to their side-effect profile, judicious use 
and appropriate patient selection is required. It should also be 
noted that the avoidance of NSAIDs postoperatively due to 
the risk of prosthetic loosening is an unsubstantiated fear that 
prevents patients from receiving evidence-based multimodal 
analgesia including NSAIDs (Husted et al. 2014). Addition-
ally, it is important to avoid inappropriate use of NSAIDs in 
patients with pre-existing kidney disease (Bjerregaard et al. 
2016b).
Summary and recommendations—The routine use of NSAIDS 
is recommended for patients without contraindications 
Evidence level—High
Recommendation grade—Strong
Gabapentinoids
Several meta-analyses have suggested that gabapentinoids 
may reduce postoperative opioid consumption, pruritus, and 
nausea following total hip and knee replacement surgery, and 
improve sleep, and indeed gabapentinoids have been included 
in exemplar peer-reviewed ERAS cohorts (Malviya et al. 
2011). However, there is a lack of evidence as to whether 
such drugs reduce pain (Lunn et al. 2015, Han et al. 2016a, 
2016b, Hamilton et al. 2016, Zhai et al. 2016, Mao et al. 2016, 
Petersen et al. 2018b), and so gabapentinoids are not recom-
mended.
Summary and recommendation—Gabapentinoids are not 
currently recommended as an adjunct in a multimodal anal-
gesia regime although further studies are indicated
Evidence level—Moderate (for not recommending)
Recommendation grade—Strong 
The use of supplemental opioid analgesia
ERAS programs emphasize the desire to minimize the use of 
opioids postoperatively and utilize alternative forms of analge-
sia. Nevertheless, their use when required is routinely reported 
in exemplar ERAS centers (Husted 2012). The efficacy of opi-
oids in reducing pain scores after surgery is well established. 
However, concerns remain regarding side effects including 
drowsiness, respiratory depression, nausea and vomiting, pru-
ritus, urinary retention, and potential risk of long-term addic-
tion. 
Currently, opioid analgesics are used if needed within the 
immediate postoperative period. They can be used to enable 
a smooth transition from peripheral techniques (e.g., LIA 
or PNBs) to non-opioid analgesia. The choice of opioid and 
method of delivery has been debated. Several studies inves-
tigated the use of controlled-release (CR) oxycodone follow-
ing hip and knee replacement. Equivalency of analgesic effect 
has been demonstrated (Rothwell et al. 2011), and CR oxyco-
done has been associated with shorter hospital length of stay 
and better tolerance compared with PCA regimes (de Beer et 
al. 2005). Furthermore, by removing the required IV access 
and connection to a PCA pump, patients are more readily able 
to function independently (e.g., dress/shower/ambulate) and 
achieve the desired discharge criteria, which reduces the need 
for supervision to assist with movement of equipment that 
can adequately be replaced with oral medication. Therefore, 
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it is strongly recommended that the use of such pumps is lim-
ited in the routine arthroplasty surgical population.
Summary and recommendation—ERAS programs seek to 
minimize the use of opioids. However, opioids such as oxy-
codone may be used when required as part of a multimodal 
approach 
Evidence level—High 
Recommendation grade—Strong 
Maintaining normothermia
The National Institute for Clinical Excellence (NICE) recom-
mends the pre-warming of patients and to maintain the active 
warming of all adults undergoing surgery throughout the intra-
operative phase (NICE 2016). Multiple series suggest that nor-
mothermia should be targeted as part of the anesthetic care of 
hip and knee replacement patients. There are many methods 
described to conserve body temperature, including pre-warming 
and humidification of anesthetic gases, warming IV and irriga-
tion fluids, and forced air-warming blankets and devices. How-
ever, the use of forced air-warming is not recommended as there 
is evidence that this is associated with an increased risk of infec-
tion (McGovern et al. 2011, Koc et al. 2017). In addition, the 
ambient temperature should be at least 21°C while the patient is 
exposed prior to active warming starting (NICE 2016). 
Summary and recommendations—Normal body temperature 
should be maintained peri- and postoperatively through 
pre-warming and the active warming of patients intraop-
eratively
Evidence level—High
Recommendation grade—Strong
Antimicrobial prophylaxis
Infection after hip and knee replacement is a serious complica-
tion that can be difficult to treat (Zimmerli et al. 2004). There 
is currently no universal internationally defined guideline for 
antibiotic/antiseptic prophylaxis for hip and knee replace-
ment, with differing national and local policies in existence 
(Voigt et al. 2015). However, a recent consensus paper does 
present recommendations for type, timing, dosing, and repeti-
tion of antimicrobials (Aboltins et al. 2019). In a meta-anal-
ysis of total joint arthroplasty, antibiotic prophylaxis reduced 
the absolute risk of wound infection by 8% and the relative 
risk by 81% compared with no prophylaxis (p < 0.001). No 
other comparison showed a statistically significant difference 
in clinical effect (AlBuhairan et al. 2008). 
Antibiotic-loaded bone cement may reduce infection rates 
after joint replacement. The evidence is more robust in hip 
compared with knee replacement (Engesaeteret al. 2006, Dale 
et al. 2009, Bohm et al. 2014). A recent systematic review and 
meta-analysis concluded that there is a paucity of well-con-
ducted trials, and evidence of the protective effect is insufficient 
to recommend routine use in knee replacement (Hinarejos et 
al. 2015). Additional research into the role of antibiotic-loaded 
bone cement may also address concerns regarding patient safety, 
risk of antibiotic-resistant microorganisms, and increased cost.
Summary and recommendations—Patients should receive 
systemic antimicrobial prophylaxis in accordance with local 
policy and availability
Evidence level—Moderate
Recommendation grade—Strong
Antithrombotic prophylaxis treatment
Hip and knee replacement may be associated with deep venous 
thrombosis (DVT) and pulmonary embolism (PE), which can 
lead to post-thrombotic syndrome (PTS) or death (Husted et 
al. 2010). Evidence-based guidelines from the American Col-
lege of Chest Physicians (ACCP) for DVT prophylaxis (Falck-
Ytter et al. 2012) suggest a minimum of 10 to 14 days’ anti-
thrombotic prophylactic use for patients undergoing hip and 
knee replacement. Comparatively, national guidelines, such as 
those made by NICE in the UK, advocate early mobilization, 
and the use of chemoprophylaxis for 28 days for hip replace-
ment and 14 days for knee replacement postoperatively (NICE 
2018). However, many of the data behind these recommen-
dations are from older studies with traditional care pathways 
with less focus on early mobilization. More recent guidelines 
from the European Society of Anaesthesiology (Venclauskas 
et al. 2018) focus on day surgery and ERAS pathways, and 
take and provide recommendations for thromboprophylaxis 
in ambulatory or fast-track surgery derived from personal and 
procedure risk factors. 
This tailored approach is consistent with the protocols pre-
sented in the large Danish observational studies of hip and 
knee replacement patients on ERAS pathways, where the inci-
dence of thromboembolic events has been found to be sub-
stantially lower compared with historical figures. This has led 
to the abandonment of routine prophylaxis in favor of selec-
tive treatment in Denmark (Husted et al. 2010, Jorgensen et 
al. 2013, Jorgensen and Kehlet 2016). A subsequent recent 
large observational study on 17,582 patients has confirmed 
the safety of in-hospital only prophylaxis for those patients 
staying less than 5 days in hospital, and highlighted that fur-
ther studies are needed to define optimal prophylaxis for high-
risk patients and those who stay in hospital longer than 5 days 
(Petersen et al. 2018a). 
Summary and recommendations—Patients should be mobi-
lized as soon as possible post-surgery and receive anti-
thrombotic prophylaxis treatment in accordance with local 
policy 
Evidence level—Moderate
Recommendation grade—Strong
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Perioperative surgical factors 
Surgical technique
There is a multitude of literature reporting that the use of spe-
cific surgical techniques and approaches can accelerate the 
achievement of discharge criteria. Studies are conflicting and 
there is no strong evidence to illustrate the isolated effect of 
any one approach against another (Aggarwal et al. 2019, Jia et 
al. 2019). In a comprehensively reported and inclusive cohort 
series of ERAS outpatient hip and knee replacement surgery, 
all hip replacements were performed using a standard postero-
lateral approach with standard prosthesis, and all knee replace-
ments were performed with a standard medial parapatellar 
approach with a standard prosthesis (Gromov et al. 2017). 
However, for example other studies on hip replacement have 
demonstrated success in same day discharge when adopting 
the direct anterior approach (Goyal et al. 2017, Berend et al. 
2018), and conversely the posterior approach has been found to 
have a lower overall complication rate compared to the anterior 
approach (Aggarwal et al. 2019). Therefore, at present insuf-
ficient evidence exists to recommend that one surgical tech-
nique (type of approach, use of a minimally invasive technique, 
prosthesis choice, or use of computer navigation or robot) over 
another will independently effect achievement of discharge cri-
teria within an ERAS set-up. 
Summary and recommendation—There is no conclusive 
evidence that choice of surgical approach accelerates the 
achievement of discharge criteria. Therefore no recommen-
dation can be given 
Evidence level—High
Recommendation grade—Strong
Use of tourniquet for knee replacement
Tourniquet use in knee replacement is used with the aim to 
reduce bleeding. However, studies show that it does not reduce 
total blood loss and its use may cause swelling and impair early 
functional recovery (Li et al. 2009, Smith and Hing 2010). 
Studies have also found an increased risk of thrombosis and 
wound complication with tourniquet use, and no evidence of 
a better quality of cementation (Prasad et al. 2007, Husted et 
al. 2014, Zhang et al. 2014, Liu et al. 2017). No difference has 
been found in preserving knee-extension strength between sur-
geries with or without a tourniquet for patients on an ERAS 
pathway (Harsten et al. 2015a); although studies on standard 
care pathways have found differences in strength after surgery 
in favor of no tourniquet (Dennis et al. 2016, Guler et al. 2016) . 
Summary and recommendation—The routine use of a tourni-
quet is not recommended
Evidence level—Moderate
Recommendation grade—Strong
Drainage
Level 1 evidence does not support the routine use of drains 
because they do not have any positive effect on the aims of their 
intended use such as for wound infections, hematomas, and 
healing complications (Parker et al. 2007, Quinn et al. 2015, 
Zhang et al. 2018). They have not been used in proven and well-
documented hip and knee ERAS pathways (Husted et al. 2014), 
with no increase in complications, and their use may in fact 
increase blood loss and transfusion rate (Kelly et al. 2014). 
Summary and recommendation—The routine use of surgical 
drains is not recommended for hip and knee replacement 
Evidence level—Moderate
Recommendation grade—Strong
Perioperative fluid management 
Recent advances in perioperative care have reduced the length 
of time that patients are nil by mouth prior to and following 
surgery. This has enabled rapid return of gastrointestinal func-
tion, particularly after major abdominal operations (NICE 
2017). Maintaining fluid balance is, therefore, a prominent 
component of general surgical ERAS pathways. However, 
due to limited intraoperative blood and fluid loss and the 
early intake of postoperative oral fluids, the term “effective 
fluid management” remains ambiguous in lower limb primary 
replacement. We are aware of only 1 study on fluid manage-
ment on an ERAS pathway for total knee replacement (Holte 
et al. 2007), which found that liberal fluid management, when 
compared with restrictive fluid management, may lead to 
hypercoagulability and a reduction in vomiting, with no dif-
ferences found for postoperative hypoxemia, exercise capac-
ity, recovery variables, or length of stay. 
There have been limited investigation of intraoperative 
techniques such as goal directed fluid therapy in hip and knee 
replacement. However, large observational studies in ERAS 
hip and knee settings have highlighted that acute kidney injury 
is most often due to pre-existing kidney disease and postoper-
ative hypotension, indicating that an increased focus on peri-
operative fluid management is important in the perioperative 
care of patients with pre-existing kidney disease (Bjerregaard 
et al. 2016b).
Care should be taken to detect and avoid electrolyte imbal-
ance including hyponatremia (Sah 2014). Intravenous fluids 
should be judiciously used with the aim of providing routine 
maintenance fluids to meet insensible losses, to maintain 
normal status of body fluid compartments and enable renal 
excretion of waste products (NICE 2017). Routine mainte-
nance provision should nearly always be a short-term measure 
and postoperative intravenous fluids discouraged in favor of 
early oral intake. 
Summary and recommendation—It is recommended that intra-
venous fluids should be used judiciously and postoperative 
intravenous fluids discouraged in favor of early oral intake 
Evidence level—Moderate
Recommendation grade—Strong
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Urinary catheter use
Urinary catheters have been used routinely for longer sur-
gical procedures to monitor urinary output and guide fluid 
resuscitation (Huang et al. 2015). However, their use has 
been questioned due to improved blood-saving and anes-
thetic practices. Studies have found no benefit in the use of 
an indwelling catheter when compared with no catheter or 
intermittent catheterization (Balderi and Carli 2010, Huang 
et al. 2015). Additionally, a low incidence of serious renal 
and urological complications has been found following 
hip and knee replacement surgery for patients on an ERAS 
pathway (Bjerregaard et al. 2016a). Therefore, the evidence 
indicates that the routine use of urinary catheters should 
be avoided. Postoperatively, a large RCT performed in an 
ERAS pathway has also demonstrated that a catheterization 
threshold of 80 0mL compared with 500 mL significantly 
reduced the need for postoperative urinary catheterization, 
without increasing urological complications (Bjerregaard et 
al. 2016b).
Summary and recommendation—The routine use of urinary 
catheters is not recommended and when used they should 
be removed as soon as the patient is able to void, ideally 
within 24 hours after completion of surgery. A catheteriza-
tion threshold of 800 mL should be used to reduce the need 
for postoperative urinary catheterization
Evidence level—Moderate
Recommendation grade—Strong
Postoperative nutritional care
No studies have investigated the direct association of early 
feeding or postoperative nutritional supplementation with the 
accelerated achievement of discharge criteria. However, return 
to normal food intake is considered an essential component of 
ERAS protocols in order to achieve return to normal behav-
iors. Early return to normal diet is a central component of all 
exemplar ERAS pathways, with units encouraging patients to 
eat and drink as soon as they feel able. 
Summary and recommendation—An early return to normal 
diet is recommended and should be promoted
Evidence level—Low 
Recommendation grade—Strong
Early mobilization
Patients should be mobilized as soon as possible following 
surgery. Outpatient surgery is now established for 13–15% of 
unselected patients, and patients are routinely discharged on 
the first and second postoperative day (Gromov et al. 2017) 
establishing early mobilization as essential. This is supported 
by level 1 evidence that early mobilization reduces length of 
stay (Guerra et al. 2015). This counteracts the long-recog-
nized adverse physiological effects associated with prolonged 
bed rest such as increased insulin resistance, muscle atrophy, 
reduced pulmonary function, impaired tissue oxygenation, 
and increased risk of thromboembolism (Harper and Lyles 
1988). 
Summary and recommendation—Patients should be mobi-
lized as early as they are able to in order in order to facili-
tate early achievement of discharge criteria 
Evidence level—Strong
Recommendation grade—Strong
Criteria-based discharge
A feature of exemplar hip and knee replacement ERAS path-
ways is that patients are discharged directly to their home 
and that objective discharge criteria are used. These criteria 
clearly define the requirements for going home from hospi-
tal, and are typified by including elements such as the ability 
to dress independently, the ability to get in and out of bed, 
the ability to sit and rise from a chair/toilet, the ability to be 
independent with personal care, and independent mobiliza-
tion with walker/ crutches, and the ability to walk > 70 m with 
crutches (Husted et al. 2011, Scott et al. 2013).
Summary and recommendation—Objective discharge crite-
ria should be used to facilitate patient discharge directly to 
their home
Evidence level—Low
Recommendation grade—Strong
Continuous improvement and audit 
The continual review of clinical practice and outcomes is a 
critical component of ongoing quality improvement in health-
care. Experience from other ERAS procedures indicates that 
the relative effectiveness of audit and feedback is likely to 
be greater when baseline adherence to recommended prac-
tice is low (Gustafsson et al. 2011). Compliance with ERAS 
processes has been found to be lower than expected in other 
procedures, with large studies in colorectal surgery reporting 
compliance levels of around 60% (ERAS Compliance Group 
2015). Therefore, an audit process that incorporates data col-
lection, and the reviewing of one’s practices against ongo-
ing gathering of evidence (performed either in-house or by 
others) is an important factor in ERAS pathways (Ljungqvist 
et al. 2017). Experience from other procedures indicates 
that the 4 main roles of an internal or external audit cycle 
are to: (1) measure clinical outcomes (such as length of stay, 
readmissions, and complications); (2) measure non-clinical 
outcomes (such as economics, and patient satisfaction/expe-
rience); (3) measure process compliance with ERAS compo-
nents; and (4) maintain the concept as dynamically as pos-
sible (including new available evidence and modifying the 
multimodal concept).
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Summary and recommendation—Routine internal and/or 
external audit of process measures, clinical outcomes, cost-
effectiveness, patient satisfaction/experience, and changes 
to the pathway is recommended
Evidence level—Low
Recommendation grade—Strong
Comment
This document outlines the recommendations of the ERAS 
Society for the perioperative management of patients under-
going hip and knee replacement surgery, and summary details 
are provided in Table 3. It is based on the best available evi-
dence as judged by these authors, which demonstrates that 
when using an ERAS pathway unselected patients can be rou-
tinely discharged from hospital 0–3 days following surgery, 
with no increased effect on morbidity or mortality (Aasvang et 
al. 2015, Gromov et al. 2017). These guidelines are an impor-
tant document in summarizing the large volume of heteroge-
neous studies across all ERAS components within hip and 
knee replacement surgery. 
The aim is to provide a starting point for implementation 
for teams new to ERAS, and as a point of reflection for expe-
rienced ERAS teams to examine their current practice. These 
Table 3. Summary of recommended interventions for the perioperative care of hip and knee replacement 
    Recommen-
   Evidence dation
Number   Item Recommendation level grade
  1 Preoperative information, Patients should routinely receive preoperative education Low Strong
 education and counseling
  2 Preoperative optimization 4 weeks’ or more smoking cessation is recommended prior to surgery. Smoking: High Strong
  Alcohol cessation programs are recommended for alcohol abusers Alcohol: Low Strong
  Anemia should be actively identified, investigated, and corrected High  
  preoperatively
  3 Preoperative fasting Clear fluids should be allowed up to 2 h and solids up to 6 h hours Moderate Strong 
  prior to induction of anesthesia
  4 Standard anesthetic protocol General anesthesia and neuraxial techniques may both be used as General  Strong
  part of multimodal anesthetic regimes anesthesia:
   moderate
   neuraxial 
   techniques: 
   Moderate 
  5 Use of local anesthetics for  Within a multimodal opioid-sparing analgesic regimen, the routine LIA in knee Strong
 infiltration analgesia and  use of LIA is recommended for knee replacement but not for hip  replacement:
 nerve blocks replacement High
  Nerve block techniques have not shown clinical superiority over LIA  
  6 Postoperative nausea and  Patients should be screened for and given multimodal PONV Moderate Strong
 vomiting prophylaxis and treatment
  7 Prevention of perioperative Tranexamic acid is recommended to reduce perioperative blood  High Strong
 blood loss loss and the requirement for postoperative allogenic blood transfusion 
  8 Perioperative oral analgesia A multimodal opioid-sparing approach to analgesia should be adopted Paracetamol: Strong
  The routine use of paracetamol and NSAIDs is recommended for  Moderate
  patients without contraindications NSAIDS: High Strong
  9 Maintaining normothermia Normal body temperature should be maintained peri- and postoperatively High Strong
10 Antimicrobial prophylaxis Patients should receive systemic antimicrobial prophylaxis Moderate Strong
11 Antithrombotic prophylaxis Patients are at increased risk of VTE and should undergo pharmacologic Moderate Strong
 treatment and mechanical prophylaxis in line with local policy 
12 Perioperative surgical factors There is no conclusive evidence that choice of surgical approach High Strong 
  accelerates the achievement of discharge criteria
  Therefore no recommendation can be given
13 Perioperative fluid management Fluid balance should be maintained to avoid over- and under-hydration Moderate Strong
14 Postoperative nutritional care An early return to normal diet should be promoted Low Strong
15 Early mobilization Patients should be mobilized as early as they are able in order to Moderate Strong 
  facilitate early achievement of discharge criteria
16 Criteria-based discharge Team-based functional discharge criteria should be used to facilitate Low Strong
  patient discharge directly to their home 
17 Continuous improvement  Routine internal and/or external audit of process measures, clinical Low Strong
 and audit outcomes, cost effectiveness, patient satisfaction/experience, and
  changes to the pathway is recommended 
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guidelines, and the testing of their implementation, as has 
been performed in other ERAS procedures, will hopefully 
allow us to consolidate consensus within the evidence base, 
and generate new evidence, through systematic prospective 
data collection and through clinical trials. 
Future work should focus on reaching the goal of the “pain 
and risk free” hip and knee replacement. In order to do this, 
we will need to better understand the pathophysiological 
mechanisms of recovery, and the potential to optimize post-
discharge functional outcomes (Wainwright and Kehlet 2019). 
This will be important because, for some of the ERAS compo-
nents, there is a strong need for properly designed randomized 
controlled studies that are sufficiently powered, performed in 
ERAS settings, and that allow for discrimination between out-
come parameters. With length of stay now reduced to between 
0 and 3 days, post-discharge markers of recovery will become 
increasing important in order to discriminate interventions. 
More specifically, work is still required in order to under-
stand how to reduce the inflammatory response postopera-
tively; how to further reduce pain; how to reduce impairment 
of physical activity and improve function quicker postopera-
tively; how to better identify patients at high risk of complica-
tions owing to psychiatric disorders, chronic renal failure, and 
orthostatic intolerance; anemia and transfusion thresholds; 
postoperative urine retention and urinary bladder catheteriza-
tion; and how to improve sleep (Wainwright and Kehlet 2019). 
Intertwined with this will be the need for further research on 
the feasibility of same-day surgery, and the type (e.g., exer-
cise therapy, cryotherapy, electro-neuromuscular stimulation), 
timing and duration of physiotherapy post-discharge (Band-
holm et al. 2018, Wainwright and Kehlet 2019).
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